What is Gevo?
Gevo, Inc. operates at the intersection of biotechnology and industrial chemistry, focusing on the development and commercialization of renewable feedstocks. The company's core value proposition lies in its ability to convert renewable resources into high-value isobutanol, which serves as a versatile building block for sustainable aviation fuel and other chemical derivatives. Through its two primary segments—Gevo, Inc. and Gevo Development/Agri-Energy—the firm manages the entire lifecycle of its products, from biocatalyst research to large-scale manufacturing. By retrofitting existing infrastructure and utilizing its proprietary fermentation technology, Gevo provides a scalable pathway for industries to reduce their carbon footprint without compromising on performance or chemical integrity.
How much funding has Gevo raised?
Gevo has raised a total of $1.7B across 11 funding rounds:
Series D
$40M
Corporate Investment
$10M
Stock Offering
$107.3M
Grant
$5M
Debt
$25.9M
Debt
$350K
Debt
$68.2M
Debt
$1.5B
Series D (2009): $40M featuring Piper Jaffray & Co.
Corporate Investment (2010): $10M backed by Lanxess AG
Stock Issuance/Offering (2011): $107.3M with participation from Undisclosed
Grant (2011): $5M led by U.S. Department of Agriculture
Debt (2014): $25.9M supported by Whitebox Advisors
Debt (2020): $350K featuring PPP
Debt (2021): $68.2M, investors not publicly disclosed
Debt (2024): $1.5B with participation from U.S. Department of Energy
Key Investors in Gevo
Khosla Ventures
A venture capital firm founded by Vinod Khosla that provides strategic advice and capital to entrepreneurs working on breakthrough technologies, with a strong focus on sustainable energy and agriculture.
U.S. Department of Energy
A Cabinet-level federal agency responsible for formulating energy policy and driving innovation in energy conservation and renewable technology development.
U.S. Department of Agriculture
A federal agency that promotes agricultural trade and production, including the BioPreferred Program which supports the expansion of markets for biobased products.
What's next for Gevo?
With the recent $1.5B injection, Gevo is entering a critical phase of operational scaling. The strategic focus will likely shift toward optimizing its production facilities and expanding the commercial reach of its biojet fuel offerings. As the regulatory environment increasingly favors low-carbon energy solutions, Gevo's ability to leverage its technological moat will be essential for maintaining its market position. Future growth will depend on the successful execution of its production roadmap and the continued integration of its renewable feedstocks into global supply chains, effectively bridging the gap between laboratory innovation and industrial-scale sustainability.
See full Gevo company page
